IVD UK Spring Meeting: Diagnostics Get New Market Access Tools – But At A Price
Executive Summary
First of two articles covering discussion at the spring 2017 meeting of the British In Vitro Diagnostics Association: The UK IVD companies are soon to get new tools designed to make market access for innovations easier and more predictable. This is welcome news, given the backdrop of Brexit and the costly route to compliance to the new EU IVD Regulation compliance.
You may also be interested in...
UK NICE’s MedTech Scan Will Give NHS Early View Of Innovation
The UK National Institute for Health and Care Excellence is working on a new database of pre-launch-phase medtech products. The aim is to give NHS providers enough time to plan for the uptake of innovative technologies and, generally, to improve the pathway between development and adoption, says NICE medtech programs director Mirella Marlow.
EU's New IVD Regulation: Key Dates And Deadlines To Shape Your Strategy
With the publication of the EU IVD Regulation in the Official Journal of the European Union, a series of deadlines for implementation and compliance have been set. Here's a timetable of what to expect.
Brexit – UK IVDs Favor Bremain By 2:1 But Don’t Knows Still High
Six weeks to the UK’s EU referendum, and the gloves are really starting come off in both the Leave and Britain Stronger in Europe camps, now that the UK parliamentary, council and mayoral elections (May 5) are out of the way.